McKesson Corporation (MCK) support and resistance · P/E 20, rev $403.43B
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
This page maps McKesson Corporation (MCK) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new MCK 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the MCK quote page for the session range and the stock page for the full model.
Not investment advice.